Influenza

People in high-risk categories should be tested and begin antiviral treatment promptly if they are hospitalized with flu symptoms, the Infectious Diseases Society of America recommends.

A new method assessing the influenza A strain provides investigators a more detailed look at flu viruses.

Lower respiratory tract infections linked to influenza were responsible for an estimated 145,000 deaths worldwide in 2017.

The reported rate of outpatient visits for influenza-like illness increased to 4.1%—well above the national baseline of 2.2%, and 1.5% greater than the rate reported midway through December.

A lead investigator explains the findings of how active choice intervention in patient's electronic health records helps to increase vaccination rates.

Overall, a new Florida State study found that 13-17 year-olds are behind all children in influenza vaccination rates.

Developed as part of a joint partnership between Sanofi and Merck, Vaxelis' commercial supply is not expected until 2020.

Investigators attributed 12% of the overall increase in vaccinations over a seven-week period to their notification program, when comparing to the previous year's vaccination rate.

Can we learn from the last flu season and prepare for the coming peak influenza activity of the current season?

Investigators test methods of incorporating smaller, localized datasets to improve influenza outbreak forecasts and increase community preparedness.

A recent study disproves a long-held belief that annual flu shots had a negative impact on vaccine effectiveness.

Severe influenza was found to be an independent risk factor for invasive aspergillosis in the largest study conducted on the concurrent pulmonary infections.

“Reassuring” results from a study of 11,692 individuals show that statin use does not affect the effectiveness of the influenza vaccine.

Officials are concerned the perpetual cycle of information sharing—by both pro- and anti-vaccination parents—is creating an echo chamber in the US.

EMR data from the 17-18 flu season shows that cell-based influenza vaccines were more effective at preventing influenza-like illness compared to standard egg-based vaccines.

The influenza virus has shown resistance to a promising new drug—favipiravir—that is being developed for widespread use, including in a flu pandemic.

With the FDA approval, Abbot now anticipates to offer new assays for use this fall.

The single-dose, oral therapy becomes the first new influenza antiviral with a novel mechanism of action approved by the FDA in nearly 20 years.

Research indicates that influenza vaccine effectiveness was low but effective in preventing influenza-related hospitalization during the 2016-2017 flu season in Canada.

Investigators find school-located influenza vaccination increased coverage and decreased school absence and influenza hospitalization.

New research suggests that flu vaccination setting is associated with vaccination timing.

High-risk individuals, such as those with cardiopulmonary and other chronic conditions, are protected from flu-related hospitalizations with the vaccine.

Roche's investigative drug could become the first single-dose oral antiviral approved for the US market in December.

Unvaccinated individuals can also benefit from the flu vaccine.

Updates in trivalent vaccines and vaccination clearance for egg-allergic patients were among the updated recommendations for pediatric influenza prevention and treatment this upcoming 2018-2019 flu season.